US 6610684
Fused azepinone cyclin dependent kinase inhibitors
expired A61PA61P35/00A61P43/00
Quick answer
US patent 6610684 (Fused azepinone cyclin dependent kinase inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61P, A61P35/00, A61P43/00